JPRN-jRCTs032230015招募中2 期
Percutaneous Cryoablation under Local Anesthesia for Thoracic Malignancies study - Coolest study
Asakura Keisuke0 个研究点目标入组 20 人开始时间: 2023年4月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Eligible patients for this study must meet all of the following criteria:
- •1) Thoracic Malignancies (with metastatic disease previously confirmed by prior biopsy or known (biopsied) primary disease): Patient with Stage4 pulmonary metastatic disease, Patient with recurrence tumor (primary lung cancer, malignant mediastinal tumor, malignant pleural tumor, malignant chest wall tumor) after the initial treatment.
- •2) Thoracic Malignancies without adaptation for the standard treatment: Patient who are not tolerable for surgery, Patient without adaptation for the radiotherapy because of the tumor location or the tumor with overlapping irradiation fields and retreating local progression after previous radiotherapy, Patient with tumor ineffective to radiotherapy and chemotherapy.
- •3) Patient has up to 3 tumors targetable by cryoablation.
- •4) Maximum size of tumor(s):Targeted tumor(s) defined as intrapulmonary with a maximum size of 3.5 cm, Targeted tumor(s) defined as mediastinal or pleural or chest wall with a maximum size of 10.0 cm.
- •5) Patient without uncontrollable primary or metastatic disease other than targeted tumor(s).
- •6) Patient must be 18 years or older, 79 years or younger.
- •7) ECOG performance status of 0-2.
- •8) Patients who are judged eligible for cryoablation by the interventional radiologists in charge of cryoablation, the thoracic surgeons in charge of cryoablation and surgery, the radiotherapists in charge of radiotherapy, and the pulmonologists in charge of chemotherapy.
- •9) The target tumor is determined to be technically achievable by the interventional radiologists in charge of cryoablation.
- •10) Patient has signed a written informed consent.
排除标准
- •Patients not eligible for participation in this study include patients who have any of the following:
- •1) INR > 1.5 or platelet count < 50,000/mm3 within 28 days prior to registration.
- •2) Patient has had chemotherapy with neutropenia to levels (ANC < 1000/mm3) within 28 days prior to registration.
- •3) Patient has uncontrolled coagulopathy or bleeding disorders.
- •4) Patient has evidence of active systemic, pulmonary, or pericardial infection.
- •5) Patient is unable to lie flat.
- •6) Patient has respiratory distress at rest.
- •7) Patient with pregnancy.
- •8) Patient with active interstitial pneumonia.
- •9) Patients who are judged ineligible by the doctor in charge.
研究者
相似试验
已完成
2 期
Safety and Efficacy of Percutaneous Cryoablation for Thoracic MalignanciesPrimary lung cancer, metastatic lung cancer, mediastinal tumor, chest wall tumorJPRN-UMIN000014996School of Medicine, Keio University200
已完成
Unknown
CRYO-SCAR studyesophageal cancerJPRN-jRCT1080225331ational Cancer Center Hospital East15
已完成
1 期
Phase 1 Clinical Trial of Percutaneous Cryoablation for Painful Musculoskeletal TumorPainful Muscloskeletal tumor (osteoid osteoma, metastatic MSK tumor)JPRN-UMIN000027828Gunma University Hospital18
招募中
3 期
Efficacy of local anesthesia with cold therapy in pain control during filling of damaged teethCTRI/2024/04/066002Dr Faizal CP
尚未招募
不适用
Safety and feasibility of the use of cryoablation in patients with brain neoplasmbrain neoplasmbrain tumors1002765610019190NL-OMON53649Erasmus MC, Universitair Medisch Centrum Rotterdam30